Global Animal Model Services Market Strategic Research Report

Scope of the Report

The global Animal Model Services market size is predicted to grow from US$ 3,912 million in 2025 to US$ 6,266 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.

Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process. Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.

The animal model services market is in a structural growth phase driven by multiple converging long-term trends. Pharmaceutical and biotech companies increasingly rely on customized, highly predictive in-vivo models to shorten development timelines and improve candidate translation; concurrently, maturation of gene-editing, humanized models and complex comorbidity models enables providers to deliver more clinically relevant solutions and capture premium service value. Moreover, heightened regulatory scrutiny and safety evaluation requirements for advanced therapeutics (e.g., cell and gene therapies) place animal model services at the core of preclinical compliance and risk management, generating durable demand for established vendors and end-to-end CROs.

Beneath the opportunities lie systemic risks: intensifying ethical and animal-welfare regulations and greater public scrutiny increase approval complexity and compliance costs; the live animal supply chain’s sensitivity around strain purity, SPF status and biosafety means any supply disruption or quality event can cause major experimental delays and reputational harm; additionally, alternative technologies (organoids, organ-on-a-chip, advanced in-vitro systems) are maturing in certain use cases and alter demand boundaries for lower-complexity applications. For companies, investments in compliance, risk mitigation and sustainable operations are now central determinants of long-term competitiveness.

Downstream demand is evolving toward both higher-complexity needs and increased outsourcing. Large pharmaceutical firms and fast-growing biotech companies prefer to outsource complex models to CROs with platform capabilities and quality assurances to reduce fixed costs and improve reproducibility, while academic groups and early-stage teams demand standardized, reproducible models and comparable datasets—creating opportunities for model standardization services and biorepository partnerships. Regionally, rising R&D investment in emerging markets drives rapid local demand for high-quality animal model services, favoring providers that can deliver locally while meeting international compliance standards.

This report presents a comprehensive overview of the global Animal Model Services market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Rats
• Mice
• Others

Segment by players, this report covers

• Charles River Laboratories
• Envigo
• Taconic Biosciences
• Jackson Laboratory
• Crown Biosciences
• Shanghai SLAC
• Shangghai Modelorg
• GenOway
• Syngene International
• Psychogenics
• Pharmaron
• Pharmalegacy
• Vitalstar Biotechnology
• JANVIER LABS

Segment by Application

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Animal Model Services market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Academic & Research Institutes, Pharmaceutical & Biotechnology Companies evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact